[1] 白颖,丛佳林,程淑莉,等.急性心肌梗死患者中糖尿病人群的临床特点及随访研究[J].中华流行病学杂志,2019,40(6):692-696. [2] Wang J, Wu X, Sun J, et al.Prediction of major adverse cardiovascular events in patients with acute coronary syndrome: Development and validation of a non-invasive nomogram model based on autonomic nervous system assessment[J].Front Cardiovasc Med, 2022,9:1053470. [3] Fang SC, Wu YL, Tsai PS.Heart Rate Variability and Risk of All-Cause Death and Cardiovascular Events in Patients With Cardiovascular Disease: A Meta-Analysis of Cohort Studies[J].Biol Res Nurs, 2020,22(1):45-56. [4] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南(2019)[J].中华心血管病杂志,2019,47(10):766-783. [5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J].中华心血管病杂志,2017,45(5):359-376. [6] 中华医学会糖尿病学分会,中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409. [7] Stoickov V, Deljanin-Ilic M, Stojanovic D, et al.The influence of type 2 diabetes mellitus on the frequency and complexity of ventricular arrhythmias and heart rate variability in patients after myocardial infarction[J].Vojnosanit Pregl,2016 ,73(11):1050-1055. [8] Szmigielska K, Jegier A.The influence of cardiac rehabilitation on heart rate variability indices in men with type 2 diabetes and coronary artery disease[J].DiabVasc Dis Res, 2021,18(3):14791641211020184. [9] Hadad R,Larsen S,Weber P,et al.Night-time heart rate variability identifies high-risk people among people with uncomplicated type 2 diabetes mellitus[J].Diabet Med, 2021, 38(7):e14559. [10] Chen Y, Jia T, Yan X, et al.Blood glucose fluctuations in patients with coronary heart disease and diabetes mellitus correlates with heart rate variability: A retrospective analysis of 210 cases[J].Niger J Clin Pract, 2020, 23(9):1194-1200. [11] Compostella L, Lakusic N, Compostella C,et al.Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization[J].World J Cardiol, 2017,9(1):27-38. [12] Shimizu W, Kubota Y, Hoshika Y, et al.Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial[J].CardiovascDiabetol,2020,19(1):148. |